At least two high-risk cytogenetic abnormalities indicate the inferior outcomes for newly diagnosed multiple myeloma patients: a real-world study in China – DocWire News

Retrospective real-world research study on multiple myeloma therapy in China CONTEXT:  This abstract with reference to full article originally published in Leuk Lymphoma Journal is a retrospective analysis of newly Continue Reading

Posted On :

Target RWE Study Shows Significant Differences in Medication Use Among Older Patients with IBD Compared to Younger Patients – PRNewswire

CONTEXT:  Publication of analysis from an ongoing 5-year longitudinal observational study of more than 4,400 patients with inflammatory bowel disease (IBD) in the Journal of Clinical Gastroenterology.  This paper includes Continue Reading

Posted On :

Celltrion Healthcare presents the first real-world data for Truxima® (biosimilar rituximab) in patients with diffuse large B-cell lymphoma at the EHA 2021 Virtual Congress – Business Wire

CONTEXT:  Presentation at the European Hematology Association (EHA) 2021 Virtual Congress of a post-approval safety study on Truxima (biosimiliar rituximab) in patients with large B-cell lymphoma.  Results showed similar results Continue Reading

Posted On :

Results from IMBRUVICA® (ibrutinib) RESONATE-2 Study Provide Up to Seven Years of Progression-Free and Overall Survival Data in First-Line Chronic Lymphocytic Leukemia (CLL) – PRNewswire

CONTEXT:  Report of new data to be presented by Abbvie at the European Hematology Association (EHA) Virtual Congress derived from the informCLLTM registry assessing how real-word treatment patterns align with Continue Reading

Posted On :